Shin Hong-Joon, Park Cheol-Kyu, Kim Tae-Ok, Ban Hee-Jung, Oh In-Jae, Kim Yu-Il, Kwon Yong-Soo, Kim Young-Chul, Lim Sung-Chul
Department of Internal Medicine, Chonnam National University Hospital, Gwangju, South Korea.
J Thorac Dis. 2016 Jun;8(6):1121-31. doi: 10.21037/jtd.2016.04.10.
The rate of hospitalization due to acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is increasing. Few studies have examined the clinical, laboratory and treatment differences between patients in general wards and those who need transfer to an intensive care unit (ICU).
We retrospectively reviewed clinical, laboratory, and treatment characteristics of 374 patients who were initially admitted to the general ward at Chonnam National University Hospital in South Korea due to AECOPD (pneumonic, 194; non-pneumonic, 180) between January 2008 and March 2015. Of these patients, 325 were managed at the medical ward during their hospitalization period (ward group), and 49 required ICU transfer (ICU group). We compared the clinical, laboratory, and treatment characteristics associated with ICU transfer between patients with AECOPD with and without pneumonia.
Male patients were 86.5% in the ward group and 79.6% in the ICU group. High glucose levels [median 154.5 mg/dL, interquartile range (IQR) 126.8-218.3 in ICU group vs. median 133.0, IQR 109.8-160.3 in ward group], high pneumonia severity index scores (median 100.5, IQR 85.5-118.5 vs. median 86.0, IQR 75.0-103.5), low albumin levels (median 2.9 g/dL, IQR 2.6-3.6 vs. median 3.4, IQR 3.0-3.7), and anemia (73.3% vs. 43.3%) independently increased the risk of ICU transfer in the pneumonic AECOPD group. High PaCO2 levels (median 53.1 mmHg in ICU group, IQR 38.5-84.6 vs. median 39.7, IQR 34.2-48.6 in ward group) independently increased the risk of ICU transfer in the non-pneumonic AECOPD group. Treatment with systemic corticosteroids (≥30 mg of daily prednisolone) during hospitalization in the medical ward independently reduced the risk of ICU transfer in both groups.
The characteristics associated with ICU transfer differed between the pneumonic and non-pneumonic AECOPD groups, and systemic corticosteroids use was associated with lower rate of ICU transfer in both groups.
慢性阻塞性肺疾病急性加重(AECOPD)导致的住院率正在上升。很少有研究探讨普通病房患者与需要转入重症监护病房(ICU)的患者之间的临床、实验室和治疗差异。
我们回顾性分析了2008年1月至2015年3月期间因AECOPD(肺炎型,194例;非肺炎型,180例)首次入住韩国全南国立大学医院普通病房的374例患者的临床、实验室和治疗特征。在这些患者中,325例在住院期间在普通内科病房接受治疗(病房组),49例需要转入ICU(ICU组)。我们比较了有肺炎和无肺炎的AECOPD患者中与转入ICU相关的临床、实验室和治疗特征。
病房组男性患者占86.5%,ICU组占79.6%。高血糖水平[ICU组中位数为154.5mg/dL,四分位数间距(IQR)为126.8 - 218.3,而病房组中位数为133.0,IQR为109.8 - 160.3]、高肺炎严重程度指数评分(中位数为100.5,IQR为85.5 - 118.5,而病房组中位数为86.0,IQR为75.0 - 103.5)、低白蛋白水平(中位数为2.9g/dL,IQR为2.6 - 3.6,而病房组中位数为3.4,IQR为3.0 - 3.7)和贫血(73.3%对43.3%)独立增加了肺炎型AECOPD组转入ICU的风险。高PaCO2水平(ICU组中位数为53.1mmHg,IQR为38.5 - 84.6,而病房组中位数为39.7,IQR为34.2 - 48.6)独立增加了非肺炎型AECOPD组转入ICU的风险。在内科病房住院期间使用全身糖皮质激素(每日泼尼松龙≥30mg)独立降低了两组转入ICU的风险。
肺炎型和非肺炎型AECOPD组中与转入ICU相关的特征不同,且两组中使用全身糖皮质激素均与较低的ICU转入率相关。